Pleasanton, CA, United States of America

Maciej Chmielarski

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Roche Molecular Systems, Inc.. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maciej Chmielarski. Retrieved from https://idiyas.com/inventor/maciej-chmielarski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Maciej Chmielarski

Introduction

Maciej Chmielarski is an accomplished inventor based in Pleasanton, CA. He has made significant contributions to the field of cancer treatment planning through his innovative designs and technologies. With a total of 3 patents, Chmielarski continues to push the boundaries of medical technology.

Latest Patents

One of his latest patents is titled "Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning." This invention aims to enhance the user experience for healthcare professionals involved in cancer treatment, providing them with interactive guidelines to improve patient outcomes.

Career Highlights

Chmielarski is currently employed at Roche Molecular Systems, Inc., where he applies his expertise in developing cutting-edge solutions for cancer treatment. His work at Roche has positioned him as a key player in the advancement of molecular diagnostics and personalized medicine.

Collaborations

Throughout his career, Chmielarski has collaborated with notable colleagues, including Qianwei Xie and Marc Mailman. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Maciej Chmielarski's contributions to the field of cancer treatment planning exemplify the impact of innovative thinking in healthcare. His patents and work at Roche Molecular Systems, Inc. highlight his commitment to improving patient care through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…